...
首页> 外文期刊>Drugs and aging >Optimal remifentanil dosage for intubation without muscle relaxants in elderly patients.
【24h】

Optimal remifentanil dosage for intubation without muscle relaxants in elderly patients.

机译:瑞芬太尼用于老年患者无气管插管的最佳剂量。

获取原文
获取原文并翻译 | 示例

摘要

Remifentanil used in combination with propofol provides adequate conditions for tracheal intubation without muscle relaxants. Delivery of the optimal dose is important to prevent poor intubation conditions and drug-related complications. No previous study has investigated the use of a remifentanil-propofol combination in elderly patients.The aim of the present study was to determine the dose of remifentanil necessary for rapid tracheal intubation without the use of muscle relaxants in elderly patients.A total of 24 patients >65 years of age with American Society of Anesthesiologists status I-II who were scheduled to undergo elective surgery under general anaesthesia were enrolled. After premedication with glycopyrrolate and midazolam, anaesthesia was induced with 1 mg/kg propofol, and a blinded dose of remifentanil was then infused over 30 s after confirming the patient's loss of consciousness. The remifentanil dose was determined using Dixon's up-and-down method, starting at 2 μg/kg. Intubation was performed 60 s after the loss of consciousness. Intubation conditions were assessed with the Stockholm score and an assessment of excellent or good condition was regarded as being clinically acceptable. The effective dose needed for acceptable intubation conditions in 50 % of the subjects (ED(50)) was determined by Dixon's up-and-down method, and the ED(50) and the effective dose needed for acceptable intubation conditions in 95 % of the subjects (ED(95)) with 95 % confidence intervals (CIs) were determined by probit analysis.In total, 24 patients were recruited and the median age (interquartile range) was 70 (66-74) years. The ED(50) of remifentanil for tracheal intubation was 1.15 (standard deviation 0.13) μg/kg. The ED(50) and ED(95) of remifentanil obtained from the probit analyses were 1.16 (95 % CI 1.01, 1.29) μg/kg and 1.39 (95 % CI 1.27, 2.13) μg/kg, respectively. Blood pressure and heart rate decreased significantly after propofol and remifentanil administration, but were within 30 % of baseline values.Combined with 1 mg/kg propofol, 1.39 (95 % CI 1.27, 2.13) μg/kg remifentanil resulted in acceptable intubation conditions within 60 s in 95 % of elderly patients without major complications.
机译:瑞芬太尼与丙泊酚联合使用可为气管插管提供足够的条件而无肌肉松弛剂。最佳剂量的输送对于防止不良插管条件和药物相关并发症很重要。以前没有研究对老年患者使用瑞芬太尼-丙泊酚联合用药进行研究。本研究的目的是确定老年患者不使用肌肉松弛剂进行快速气管插管所需的瑞芬太尼剂量。入选美国麻醉医师学会I-II年龄> 65岁并计划在全身麻醉下进行择期手术的患者。在用格隆溴铵和咪达唑仑进行预用药后,用1 mg / kg异丙酚诱导麻醉,然后在确认患者失去知觉后30 s内输注盲方剂量的瑞芬太尼。使用Dixon的上下测定法确定瑞芬太尼的剂量,起始剂量为2μg/ kg。失去意识后60 s进行插管。用Stockholm评分评估插管状况,对优良或良好状况的评估被认为是临床可接受的。通过Dixon的上下法确定50%受试者的可接受插管条件所需的有效剂量,而95%受试者中ED(50)和可接受插管条件所需的有效剂量通过概率分析确定了具有95%置信区间(CIs)的受试者(ED(95))。总共招募了24例患者,中位年龄(四分位间距)为70(66-74)岁。瑞芬太尼用于气管插管的ED(50)为1.15(标准偏差0.13)μg/ kg。从概率分析获得的瑞芬太尼的ED(50)和ED(95)分别为1.16(95%CI 1.01、1.29)μg/ kg和1.39(95%CI 1.27、2.13)μg/ kg。丙泊酚和瑞芬太尼给药后血压和心率显着下降,但在基线值的30%以内。与1 mg / kg丙泊酚合用1.39(95%CI 1.27,2.13)μg/ kg瑞芬太尼导致60内可接受的插管条件95%的老年患者无重大并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号